Skip to main content
. 2014 Sep 18;3(4):663–675. doi: 10.1016/j.stemcr.2014.08.004

Figure 2.

Figure 2

Morphology and MAGEA4 and SCP3 Expression in the Testes of Cryptorchid Patients and OA Patients

(A and B) H&E staining showing the morphology of testicular tissues from OA patients (A) and cryptorchid patients (B). Scale bar in (A), 20 μm, and scale bar in (B), 50 μm.

(C and D) Immunohistochemistry revealing MAGEA4 expression in testis sections from OA patients (C) and cryptorchid patients (D). Scale bars in (C) and (D), 50 μm.

(E and F) Replacement of anti-MAGEA4 by normal mouse IgG in testis sections of OA patients (E) and cryptorchid patients (F) served as negative controls. Scale bars in (E) and (F), 70 μm.

(G and H) Immunohistochemistry revealing SCP3 expression in testis sections from OA patients (G) and cryptorchid patients (H). Scale bars in (G) and (H), 30 μm.

(I and J) Replacement of anti-SCP3 by normal rabbit IgG in testis sections from OA patients (I) and cryptorchid patients (J) was used as negative controls. Scale bars in (I) and (J), 30 μm.